Cargando…
Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia
The nasal epithelium is a key portal for infection by respiratory viruses such as SARS-CoV-2 and represents an important target for prophylactic and therapeutic interventions. In the present study, we test the safety and efficacy of a newly developed nasal spray (AM-301, marketed as Bentrio) against...
Autores principales: | Fais, Fabio, Juskeviciene, Reda, Francardo, Veronica, Mateos, Stéphanie, Guyard, Manuela, Viollet, Cécile, Constant, Samuel, Borelli, Massimo, Hohenfeld, Ilja P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999825/ https://www.ncbi.nlm.nih.gov/pubmed/35409423 http://dx.doi.org/10.3390/ijms23074062 |
Ejemplares similares
-
Barrier‐forming, drug‐free nasal spray reduces allergic symptoms induced by house dust mite allergen
por: Couroux, Patricia, et al.
Publicado: (2023) -
Efficacy and Safety of a Drug-Free, Barrier-Forming Nasal Spray for Allergic Rhinitis: Randomized, Open-Label, Crossover Noninferiority Trial
por: Nehrig, Julian, et al.
Publicado: (2023) -
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
por: Pizzorno, Andrés, et al.
Publicado: (2020) -
On the Use and the Abuse of Nasal Sprays
por: Roy, Dunbar
Publicado: (1901) -
Hypoxia Increases Epithelial Permeability in Human Nasal Epithelia
por: Min, Hyun Jin, et al.
Publicado: (2015)